Levin Capital Strategies, L.P. Alpha Tau Medical Ltd. Transaction History
Levin Capital Strategies, L.P.
- $952 Million
- Q2 2024
A detailed history of Levin Capital Strategies, L.P. transactions in Alpha Tau Medical Ltd. stock. As of the latest transaction made, Levin Capital Strategies, L.P. holds 280,459 shares of DRTS stock, worth $633,837. This represents 0.07% of its overall portfolio holdings.
Number of Shares
280,459
Previous 338,764
17.21%
Holding current value
$633,837
Previous $999,000
29.03%
% of portfolio
0.07%
Previous 0.1%
Shares
5 transactions
Others Institutions Holding DRTS
# of Institutions
26Shares Held
1.3MCall Options Held
0Put Options Held
0-
Hoyle Cohen, LLC269KShares$608,1380.05% of portfolio
-
High Tower Advisors, LLC Chicago, IL231KShares$521,3910.0% of portfolio
-
ETF Managers Group, LLC Summit, NJ66.3KShares$149,8960.01% of portfolio
-
Satovsky Asset Management LLC53.6KShares$121,1490.03% of portfolio
-
Private Advisor Group, LLC47.6KShares$107,5370.0% of portfolio
About Alpha Tau Medical Ltd.
- Ticker DRTS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,011,296
- Market Cap $156M
- Description
- Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast canc...